Previous 10 | Next 10 |
Antibiotic resistance is a growing global public health emergency. Melinta Therapeutics ( MLNT ) has decided to take up the critical mission of overcoming antibiotic resistance with their broad spectrum antibiotic portfolio. Unfortunately, the market doesn’t see the opportunity in addre...
Source: Shutterstock The stock market has continued to edge higher and the two major indexes, the Nasdaq ( QQQ ) and S&P 500 ( SPY ), touched the all-time high milestone last week. The steady gain reflects a diminishing concern relating to the pace of a global economic slowdown, as m...
Aratana Therapeutics (NASDAQ: PETX ) +37% on Elanco takeover . More news on: Aratana Therapeutics, Inc., Regional Health Properties, Inc., Reebonz Holding Limited, Stocks on the move, Read more ...
Aurora Cannabis (NYSE: ACB ) initiated with Buy rating and C$16.50 (35% upside) price target at Desjardins. Shares up 1% premarket on the heels of its license deal with EnWave. More news on: Aurora Cannabis Inc., Gilead Sciences, Inc., Tocagen Inc., Healthcare stocks news, Stoc...
The Medicines Company (MDCO) Q1 2019 Earnings Conference Call April 25, 2019 8:30 AM Company Participants Krishna Gorti - VP, IR Mark Timney - CEO Christopher Visioli - CFO Peter Wijngaard - CDO Conference Call Participants Paul Choi - Goldman Sachs Tazeen Ahmed - Bank ...
Medicines ( MDCO ) Q1 results : Revenues: $0; R&D Expense: $27M (-33.2%); SG&A: $17M (-41.4%); Net Loss: ($59.9M) (+29.4%); Loss Per Share: ($0.80) (+30.4%); Non-GAAP Net Loss: ($46M) (+18.4%); Non-GAAP Loss Per Share: ($0.62) (+18.4%). More news on: The Medicines Company, Healthc...
Inclisiran’s unique profile, vast global market opportunity and long-dated exclusivity set the stage for potentially significant shareholder value creation Independent Data Monitoring Committee recommends continuation of inclisiran Phase 3 clinical trials after sixth un-blind...
The Medicines Company (NASDAQ:MDCO) will host a conference call and audio webcast on Thursday, April 25, 2019 at 8:30 a.m. EDT to discuss its first quarter 2019 financial results and operational developments. The conference call may be accessed by telephone as follows: U.S./Canada: (...
Respect is tendered with pleasure only where it is not exacted .” - Anne Robert Jacques Turgot Today, we take a look at a concern that is transforming itself with a new direction and CEO. The stock is well off its highs of last summer and seeing a large amount of recent insider buy...
The following slide deck was published by The Medicines Company in conjunction with this Read more ...
News, Short Squeeze, Breakout and More Instantly...
The Medicines Company Company Name:
MDCO Stock Symbol:
NASDAQ Market:
The Medicines Company Website:
The Medicines Company (the “Company”) today provided notice of a Make-Whole Fundamental Change to holders of its (i) 2.50% Convertible Senior Notes due 2022 (the “2022 Notes”), (ii) 2.75% Convertible Senior Notes due 2023 (the “2023 Notes”) and (ii) 3...
Shares of Meritor (NYSE: MTOR) , a global supplier of drivetrain, braking, and other aftermarket automotive solutions for vehicles, jumped as high as 16% Tuesday morning after markets digested the announcement that Meritor will join the S&P SmallCap 600 index. The announcement actually c...
NEW YORK , Dec. 30, 2019 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600 effective prior to the open of trading on Monday, January 6 : NexPoint Residential Trust Inc. (NYSE: NXRT) will replace Avon Products Inc. (NYSE: AVP). Natura...